A chimeric peptide composed of a dermaseptin derivative and an RNA III-inhibiting peptide prevents graft-associated infections by antibiotic-resistant staphylococci

Antimicrobial Agents and Chemotherapy

Volumn 48, Issue 7, 2004, Pages 2544-2550

  Balaban, Naomi ^a   Gov, Yael ^a   Giacometti, Andrea ^c   Cirioni, Oscar ^c   Ghiselli, Roberto ^d   Mocchegiani, Federico ^d   Orlando, Fiorenza ^d   D'Amato, Giuseppina ^c   Saba, Vittorio ^d   Scalise, Giorgio ^c   Bernes, Sabina ^b   Mor, Amram ^b  

^a TEL AVIV UNIVERSITY   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^c UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^d INRCA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CHIMERIC PROTEIN; DERMASEPTIN; HEPTAPEPTIDE; HYBRID PROTEIN; RIFAMPICIN; RNA III INHIBITING PEPTIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERICIDAL ACTIVITY; BIOFILM; CONTROLLED STUDY; DEVICE INFECTION; DOSE RESPONSE; DRUG MECHANISM; DRUG POTENCY; ENCAPSULATION; FOREIGN BODY; GRAFT INFECTION; INFECTION PREVENTION; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PRIORITY JOURNAL; RAT; RNA SYNTHESIS; STAPHYLOCOCCUS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS INFECTION;

AMPHIBIAN PROTEINS; ANIMALS; ANTI-INFECTIVE AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; CIRCULAR DICHROISM; DRUG RESISTANCE, BACTERIAL; MALE; MICROBIAL SENSITIVITY TESTS; OLIGOPEPTIDES; PEPTIDES; POLYETHYLENE TEREPHTHALATES; RATS; RATS, WISTAR; RECOMBINANT FUSION PROTEINS; SPECTROPHOTOMETRY, ULTRAVIOLET; STAPHYLOCOCCAL INFECTIONS; TRANSPLANTS;

EID: 3042533905     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.48.7.2544-2550.2004     Document Type: Article

References (74)

1. Andreu, A., and L. Rivas. 1998. Animal antimicrobial peptides: an overview. Biopolymers 47:415-433.
2. Balaban, N., L. V. Collins, J. S. Cullor, E. B. Hume, E. Medina-Acosta, O. Vieira da Motta, R. O'Callaghan, P. V. Rossitto, M. E. Shirtliff, L. Silveira, A. Tarkowski, and J. V. Torres. 2000. Prevention of diseases caused by Staphylococcus aureus using the peptide RIP. Peptides 21:1301-1311.
3. Balaban, N., A. Giacometti, O. Cirioni, Y. Gov, et al. 2003. Use of the quorum-sensing inhibitor RNA III-inhibiting peptide to prevent biofilm formation in vivo by drug-resistant Staphylococcus epidermidis. J. Infect. Dis. 187:625-630.
4. Balaban, N., T. Goldkorn, Y. Gov, M. Hirshberg, N. Koyfman, H. R. Matthews, R. T. Nhan, B. Singh, and O. Uziel. 2001. Regulation of Staphylococcus aureus pathogenesis via target of RNA III-activating protein (TRAP). J. Biol. Chem. 276:2658-2667.
5. Balaban, N., T. Goldkorn, R. T. Nhan, et al. 1998. Autoinducer of virulence as a target for vaccine and therapy against Staphylococcus aureus. Science 280:438-440.
6. Balaban, N., Y. Gov, A. Bitler, and J. R. Boelaert. 2003. Prevention of Staphylococcus aureus biofilm on dialysis catheters and adherence to human cells. Kidney Int. 63:340-345.
7. Barie, P. S. 1998. Antibiotic-resistant gram-positive cocci: implications for surgical practice. World J. Surg. 22:118-126.
8. Blondelle, E. S., and K. Lohner. 2000. Combinatorial libraries: a tool to design antimicrobial and antifungal peptide analogues having lytic specificities for structure-activity relationship studies. Biopolymers 55:74-87.
9. Boman, H. G. 1995. Peptide antibiotics and their role in innate immunity. Annu. Rev. Immunol. 13:61-92.
10. Brand, G. D., J. R. Leite, L. P. Silva, et al. 2002. Dermaseptins from Phyllomedusa oreades and Phyllomedusa distincta. Anti-Trypanosoma cruzi activity without cytotoxicity to mammalian cells. J. Biol. Chem. 277:49332-49340.
11. Carratala, J. 2002. The antibiotic-lock technique for therapy of 'highly needed' infected catheters. Clin. Microbiol. Infect. 8:282-289.
12. Chen, J., T. J. Falla., H. Liu., M. A. Hurst., et al. 2000. Development of protegrins for the treatment and prevention of oral mucositis: structure-activity relationships of synthetic protegrin analogues. Biopolymers 55:88-98.
13. Chicharro, C., C. Granata, R. Lozano, D. Andreu, and L. Rivas. 2001. N-terminal fatty acid substitution increases the leishmanicidal activity of CA(1-7)M(2-9), a cecropin-melittin hybrid peptide. Antimicrob. Agents Chemother. 45:2441-2449.
14. Cirioni, O., A. Giacometti, R. Ghiselli, et al. 2003. Prophylactic efficacy of topical temporin A and RNA III-inhibiting peptide in a subcutaneous rat pouch model of graft infection attributable to staphylococci with intermediate resistance to glycopeptides. Circulation 108:767-771.
15. Costerton, J. W., P. S. Stewart, and E. P. Greenberg. 1999. Bacterial biofilms: a common cause of persistent infections. Science 284:1318-1322.
16. Dagan, A., L. Efron, L. Gaidukov, A. Mor, and H. Ginsburg. 2002. In vitro antiplasmodium effects of dermaseptin S4 derivatives. Antimicrob. Agents Chemother. 46:1059-1066.
17. Duclohier, H., and H. Wroblewski. 2001. Voltage-dependent pore formation and antimicrobial activity by alamethicin and analogues. J. Membr. Biol. 184:1-12.
18. Edlund, C., M. Hedberg, A. Engstrom, J. I. Flock, and D. Wade. 1998. Antianaerobic activity of a cecropin-melittin peptide. Clin. Microbiol. Infect. 4:181-185.
19. Feder, R., A. Dagan, and A. Mor. 2000. Structure-activity relationship study of antimicrobial dermaseptin S4 showing the consequences of peptide oligomerization on selective cytotoxicity. J. Biol. Chem. 275:4230-4238.
20. Feder, R., R. Nehushtai, and A. Mor. 2001. Affinity driven molecular transfer from erythrocyte membrane to target cells. Peptides 22:1683-1690.
21. Friedrich, C. L., D. Moyles, T. J. Beveridge, and R. E. Hancock. 2000. Antibacterial action of structurally diverse cationic peptides on gram-positive bacteria. Antimicrob. Agents Chemother. 44:2086-2092.
22. Gaidukov, L., A. Fish, and A. Mor. 2003. Analysis of membrane-binding properties of dermaseptin analogues: relationships between binding and cytotoxicity. Biochemistry 42:12866-12874.
23. Ganz, T., and R. Lehrer. 1998. Antimicrobial peptides of vertebrates. Curr. Opin. Immunol. 10:41-44.
24. Gazit, E., A. Boman, H. G. Boman, and Y. Shai. 1995. Interaction of the mammalian antibacterial peptide cecropin P1 with phospholipid vesicles. Biochemistry 34:11479-11488.
25. Ge, Y., D. L. MacDonald, K. J. Holroyd, C. Thornsberry, H. Wexler, and M. Zasloff. 1999. In vitro antibacterial properties of pexiganan, an analog of magainin. Antimicrob. Agents Chemother. 43:782-788.
26. Ghosh, J. K., D. Shaool, P. Guillaud, L. Ciceron, D. Mazier, I. Kustanovich, Y. Shai, and A. Mor. 1997. Selective cytotoxicity of dermaseptin S3 toward intraerythrocytic Plasmodium falciparum and the underlying molecular basis. J. Biol. Chem. 272:31609-31616.
27. Giacometti, A., O. Cirioni, Y. Gov, R. Ghiselli, D. Del Prete, F. Mocchegiani, V. Saba, F. Orlando, G. Scalise, N. Balaban, and G. Dell'Acqua. 2003. RNA III-inhibiting peptide inhibits in vivo biofilm formation by drug-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 47:1979-1983.
28. Gottenbos, B., D. W. Grijpma, H. van der Mei, J. Feijen, and H. J. Busscher. 2001. Antimicrobial effects of positively charged surfaces on adhering Gram-positive and Gram-negative bacteria. J. Antimicrob. Chemother. 48:7-13.
29. Gov, Y., A. Bitler, G. Dell'Acqua, J. V. Torres, and N. Balab. 2001. RNA III-inhibiting peptide (RIP), a global inhibitor of Staphylococcus aureus pathogenesis: structure and function analysis. Peptides 22:1609-1620.
30. Hancock, R. E. 1997. Peptide antibiotics. Lancet 349:418-422.
31. Hancock, R. E., and R. Lehrer. 1998. Cationic peptides: a new source of antibiotics. Trends Biotechnol. 16:82-90.
32. Hariton-Gazal, E., R. Feder, A. Mor, A. Graessmann, A. Brack-Werner, D. Jans, C. Gilon, and A. Loyter. 2001. Targeting of nonkaryophilic cell-permeable peptides into the nuclei of intact cells by covalently attached nuclear localization signals. Biochemistry 41:9208-9214.
33. Heller, W. T., A. J. Waring, R. I. Lehrer, and H. W. Huang. 1998. Multiple states of beta-sheet peptide protegrin in lipid bilayers. Biochemistry 37:17331-17338.
34. Henke, P. K., T. M. Bergamini, S. M. Rose, and J. D. Richardson. 1998. Current options in prosthetic vascular graft infection. Am. Surg. 64:39-45.
35. Huang, H. W. 2000. Action of antimicrobial peptides: two-state model. Biochemistry 39:8347-8352.
36. Huebner, J., and D. A. Goldman. 1999. Coagulase-negative staphylococci: role as pathogens. Annu. Rev. Med. 50:233-236.
37. Kustanovich, I., D. E. Shalev, M. Mikhlin, L. Gaidukov, A. Mor. 2002. Structural requirements for potent versus selective cytotoxicity for antimicrobial dermaseptin S4 derivatives. J. Biol. Chem. 277:16941-16951.
38. Ladokhin, A. S., M. E. Selsted, and S. H. White. 1997. Sizing membrane pores in lipid vesicles by leakage of co-encapsulated markers: pore formation by melittin. Biophys. J. 72:1762-1766.
39. Levy, O. 2000. Antimicrobial proteins and peptides of blood: templates for novel antimicrobial agents. Blood 96:2664-2672.
40. Linnola, R. 2001. Staphylococcus epidermidis and intraocular lenses. Ophthalmology 108:1518-1519.
41. Lowy, F. D. 1998. Staphylococcus aureus infections. N. Engl. J. Med. 339:520-532.
42. Lowy, F. D. 2003. Antimicrobial resistance: the example of Staphylococcus aureus. J. Clin. Investig. 111:1265-1273.
43. Ludtke, S. J., K. He, Y. Wu, and H. W. Huang. 1994. Cooperative membrane insertion of magainin correlated with its cytolytic activity. Biochim. Biophys. Acta 1190:181-184.
44. Mah, T. F., and G. A. O'Toole. 2001. Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol. 9:34-39.
45. Maloy, L. W., and U. P. Kari. 1995. Structure-activity studies on magainins and other host defense peptides. Biopolymers 37:105-122.
46. Marr, K. A. 2000. Staphylococcus aureus bacteremia in patients undergoing hemodialysis. Semin. Dialysis 13:23-29.
47. Merrifield, R. B., E. L. Merrifield, P. Juvvadi, D. Andreu, and H. G. Boman. 1994. Design and synthesis of antimicrobial peptides. Ciba Found Symp. 186:5-20.
48. Miller, M. B., and B. L. Bassler. 2001. Quorum sensing in bacteria. Annu. Rev. Microbiol. 55:165-199.
49. Moll, G. N., S. Brul, W. N. Konings, and A. J. Driessen. 2000. Comparison of the membrane interaction and permeabilization by the designed peptide Ac-MB21-NH2 and truncated dermaseptin S3. Biochemistry 39:11907-11912.
50. Mor, A. 2001. Antimicrobial peptides. In A. Seidel (ed.), The Kirk-Othmer encyclopedia of chemical technology. John Wiley & Sons, New York, N.Y.
51. Mor, A., M. Amiche, and P. Nicolas. 1994. Structure, synthesis, and activity of dermaseptin b, a novel vertebrate defensive peptide from frog skin: relationship with adenoregulin. Biochemistry 33:6642-6650.
52. Mor, A., K. Hani, and P. Nicolas. 1994. The vertebrate peptide antibiotics dermaseptins have overlapping structural features but target specific microorganisms. J. Biol. Chem. 269:31635-31640.
53. Mor, A., V. H. Nguyen, A. Delfour, S. D. Migliore, and P. Nicolas. 1991. Isolation, amino acid sequence, and synthesis of dermaseptin, a novel antimicrobial peptide of amphibian skin. Biochemistry 30:8824-8830.
54. Mor, A., and P. Nicolas. 1994. Isolation and structure of novel defensive peptides from frog skin. Eur. J. Biochem. 219:145-154.
55. Mor, A., and P. Nicolas. 1994. The NH2-terminal alpha-helical domain 1-18 of dermaseptin is responsible for antimicrobial activity. J. Biol. Chem. 269:1934-1939.
56. Navon-Venezia, S., R. Feder, L. Gaidukov, Y. Carmeli, and A. Mor. 2002. Antibacterial properties of dermaseptin S4 derivatives with in vivo activity. Antimicrob. Agents Chemother. 46:689-694.
57. Nicolas, P., and A. Mor. 1995. Peptides as weapons against microorganisms in the chemical defense system of vertebrates. Annu. Rev. Immunol. 49:277-304.
58. Oren, Z., and Y. Shai. 2000. Cyclization of a cytolytic amphipathic alpha-helical peptide and its diastereomer: effect on structure, interaction with model membranes, and biological function. Biochemistry 39:6103-6114.
59. Oren, Z., and Y. Shai. 1998. Mode of action of linear amphipathic alpha-helical antimicrobial peptides. Biopolymers 47:451-463.
60. Patrzykat, A., C. L. Friedrich, L. Zhang, V. Mendoza, and R. E. Hancock. 2002. Sublethal concentrations of pleurocidin-derived antimicrobial peptides inhibit macromolecular synthesis in Escherichia coli. Antimicrob. Agents Chemother. 46:605-614.
61. Piers, K. L., M. H. Brown, and R. E. Hancock. 1994. Improvement of outer membrane-permeabilizing and lipopolysaccharide-binding activities of an antimicrobial cationic peptide by C-terminal modification. Antimicrob. Agents Chemother. 38:2311-2316.
62. Pouny, Y., D. Rapaport, A. Mor, P. Nicolas, and Y. Shai. 1992. Interaction of antimicrobial dermaseptin and its fluorescently labeled analogues with phospholipid membranes. J. Biol. Chem. 31:12416-12423.
63. Sardelic, F., P. Y. Ao, D. A. Taylor, and J. P. Fletcher. 1996. Prophylaxis against Staphylococcus epidermidis vascular graft infection with rifampicin-soaked, gelatin-sealed Dacron. Cardiovasc. Surg. 4:389-392.
64. Schierholz, J. M., and J. Beuth. 2001. Implant infections: a haven for opportunistic bacteria. J. Hosp. Infect. 49:87-93.
65. Shai, Y. 2002. Mode of action of membrane active antimicrobial peptides. Biopolymers 66:236-248.
66. Shai, Y. 1999. Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides. Biochim. Biophys. Acta 1462:55-70.
67. Shin, S. Y., J. H. Kang, M. K. Lee, S. Y. Kim, Y. Kim, and K. S. Hahm. 1998. Cecropin A-magainin 2 hybrid peptides having potent antimicrobial activity with low hemolytic effect. Biochem. Mol. Biol. Int. 44:1119-1126.
68. Sokolov, Y., T. Mirzabekov, D. W. Martin, R. I. Lehrer, and B. L. Kagan. 1999. Membrane channel formation by antimicrobial protegrins. Biochim. Biophys. Acta 1420:23-29.
69. Stewart, P. S., and J. W. Costerton. 2001. Antibiotic resistance of bacteria in biofilms. Lancet 358:135-138.
70. Strahilevitz, J., A. Mor, P. Nicolas, and Y. Shai. 1994. Spectrum of antimicrobial activity and assembly of dermaseptin-b and its precursor form in phospholipid membranes. J. Biol. Chem. 33:10951-10960.
71. Tiller, J. C., C. J. Liao, K. Lewis, and A. M. Klibanov. 2001. Designing surfaces that kill bacteria on contact. Proc. Natl. Acad. Sci. USA 98:5981-5985.
72. Tossi, A., L. Sandri, and A. Giangaspero. 2000. Amphipathic, alpha-helical antimicrobial peptides. Biopolymers 55:4-30.
73. Vieira-da-Motta, O., X. Damasceno, P. Ribeiro, W. Dias da Silva, and E. Medina-Acosta. 2001. RNA III inhibiting peptide (RIP), a global inhibitor of Staphylococcus aureus pathogenesis: structure and function analysis. Peptides 22:1621-1627.
74. Zasloff, M. 2002. Antimicrobial peptides of multicellular organisms. Nature 415:389-395.